News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Mallinckrodt plc Reports Fiscal 2014 Third Quarter Financial Results; Updates Full-Year 2014 Guidance, Increasing Net Sales And Adjusted Diluted Earnings Per Share


8/7/2014 11:20:45 AM

free biotech news Get the latest biotech news where you want it. Sign up for the 

free GenePool newsletter today!

Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, today reported results for the third quarter of fiscal 2014, which ended June 27, 2014. The company also announced that it updated guidance for fiscal 2014 reflecting the strong performance of the company’s base business, and recently acquired OFIRMEV (acetaminophen) injection.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES